Skip to content

Ultrasonographical of Suprarenal Gland in High Risk Neonates

Ultrasonographical Study of Suprarenal Gland in High Risk Neonates

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06575504
Acronym
USSGneonates
Enrollment
105
Registered
2024-08-28
Start date
2023-11-15
Completion date
2024-08-15
Last updated
2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insuffeciency of the Suprarenal Gland

Keywords

Doppler Ultrasound, Suprarenal gland, high risk neonates, NICU

Brief summary

Observation study The aim is to study the suprarenal blood flow among high-risk neonates and its relation to the risk factors

Detailed description

Ultrasonographical study of the suprarenal gland in high risk newborn infants Al-Zhrraa University hospital Sample size 105 Inclusion criteria: 1- High-risk newborn 2- Need NICU admission Exclusion criteria: Cases with Major congenital anomalies and NEC Primary outcome: Abnormal suprarenal blood flow Informed consent will be obtained from all parents and mothers of the newborns enrolled in the study. All cases will be subjected to - Full history taking: (prenatal -natal - postnatal). According to the routine admission sheet of NICU of Alzahraa University Hospital, Faculty of Medicine for girls, AL-Azhar University, Cairo, Egypt. Through clinical examination (APGAR score -estimation of gestational age using modified Ballard score "Ballard, 1991" - body weight - severity of respiratory illness using Downs score and Silverman's score). Laboratory investigations: * Blood gases. * Serum electrolytes and blood glucose. * CBC. CRP. * Liver and kidney functions. Radiological evaluation: in the form of Abdominal and chest x-ray. Ultrasonographical studies were done for suprarenal gland blood flow. - Statistical Analysis, Data were collected, revised, coded, and entered into the statistical package for social science (SPSS)

Interventions

DIAGNOSTIC_TESTUltrasonographical examination

Study size and Doppler / blood flow / of the suprarenal gland

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 10 Days
Healthy volunteers
No

Inclusion criteria

* High risk neonates

Exclusion criteria

* congenital anomalies

Design outcomes

Primary

MeasureTime frameDescription
Adrenocortical insufficiency12 monthsBlood flow velocity RI ED TMAX

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026